“Takecab Tablets 20mg” is a prescription medicine (Rx) in Japan. 2. IMPORT (SUPPORTING) DOCUMENTS. Certificate of Origin (CoO), Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of “Takecab Tablets 20mg” are available. *PIL and SmPC are written in Japanese. 3. Clinical trials.

2015年2月26日 · TAKECAB, discovered by Takeda, is a new medicine for treating acid-related diseases with a novel mechanism of action called potassium-competitive acid blockers (P-CABs) which competitively inhibits the binding of potassium ions to H +,K +-ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal ...

2025年1月22日 · 動物試験（ラット）において、最大臨床用量（40mg/日）におけるボノプラザンの曝露量（AUC）の約28倍を超える曝露量で、胎児体重及び胎盤重量の低値、外表異常（肛門狭窄及び尾の異常）、並びに内臓異常（膜性部心室中隔欠損及び鎖骨下動脈起始異常）が認められている。 治療上の有益性及び母乳栄養の有益性を考慮し、授乳の継続又は中止を検討すること。

2024年11月7日 · タケキャブ錠20mg（Takecab Tablets 20mg）是一种用于治疗胃溃疡、 十二指肠溃疡 和逆流性食道炎的药物。 其主要成分是ボノプラザンフマル酸塩（Vonoprazan Fumarate），属于钾离子竞争型酸 阻滞剂 （P-CAB），具有强效而持久的抑酸作用。 相较于传统的 质子泵抑制剂 （PPI），タケキャブ錠20mg在治疗胃肠道疾病方面展示出更显著的疗效和更少的副作用。 反流性食管炎 （Reflux Esophagitis，RE）是消化系统的常见疾病，在中国普通 …

2023年6月23日 · Takecab can help alleviate symptoms associated with GERD and other conditions involving excess stomach acid production. It works by blocking the enzyme that pumps acid into the stomach, thereby reducing the amount of acid present in the stomach and preventing it from flowing back up into the esophagus.

- In general, for adults, take 1 tablet (20 mg of vonoprazan) at a time, once a day. Duration of taking the medicine is up to 8 weeks for gastric ulcer; 6 weeks for duodenal ulcer. - In general, duration of taking the medicine is up to 4 weeks. If the effect is insufficient, the treatment may be continued for up to 8 weeks.

Indicated for a range of conditions including gastric and duodenal ulcers, as well as reflux esophagitis, Takecab tablets offer efficacious therapy. Particularly noteworthy is their capacity to prevent the recurrence of gastric and duodenal ulcers induced by low-dose aspirins or other nonsteroidal anti-inflammatory drugs.

Takecab tablets are effective for the treatment of gastric or duodenal ulcer, reflux esophagitis and for suppression of recurrence of gastric or duodenal ulcer associated with low-dose aspirin or nonsteroidal anti-inflammatory drug medication.

カリウムイオンに競合的な様式でプロトンポンプを阻害することによって、胃酸の生成を抑制します。 通常、胃・十二指腸潰瘍、逆流性食道炎の治療、低用量アスピリン・非ステロイド性抗炎症薬服用時における胃・十二指腸潰瘍の再発抑制に用いられます。 它以与钾离子竞争的方式抑制质子泵，从而抑制了胃酸的产生。 通常用于治疗胃溃疡，十二指肠溃疡，反流性食管炎的治疗，并在服用小剂量阿司匹林/非甾体抗炎药时用于防止胃/十二指肠溃疡的复发。 胃溃疡，十二指肠 …

2018年5月18日 · Takecab®被批准用于治疗胃溃疡、十二指肠溃疡和反流性食道炎，预防长期低剂量使用阿司匹林或非甾体抗炎药导致的胃溃疡和十二指肠溃疡复发，辅助...